GREAT POINT PARTNERS LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Research Alliance Corporation III 13G RACC · G75226103	RACC	G75226103	6.5%	504,891	13G	9/11/2026 Event 9/4/2026
Great Point Partners, LLC			6.5%	504,891
Dr. Jeffrey R. Jay, M.D.			6.5%	504,891
Ms. Lillian Nordahl			6.5%	504,891
JATT III Acquisition Corp 13G JTTT · G5080G109	JTTT	G5080G109	5.8%	450,000	13G	9/2/2026 Event 8/26/2026
Great Point Partners, LLC			5.8%	450,000
Dr. Jeffrey R. Jay, M.D.			5.8%	450,000
Ms. Lillian Nordahl			5.8%	450,000
Promis Neurosciences Inc. 13G/A PMN · 74346M505	PMN	74346M505	7.7%	736,881	13G/A	8/14/2026 Event 6/30/2026
Great Point Partners, LLC			7.7%	736,881
Dr. Jeffrey R. Jay, M.D.			7.7%	736,881
Ms. Lillian Nordahl			7.7%	736,881
JATT II Acquisition Corp. 13G/A JATT · G50765109	JATT	G50765109	6.2%	500,000	13G/A	8/14/2026 Event 6/30/2026
Great Point Partners, LLC			6.2%	500,000
Dr. Jeffrey R. Jay, M.D.			6.2%	500,000
Ms. Lillian Nordahl			6.2%	500,000
SCYNEXIS, Inc. 13G/A SCYX · 811292309	SCYX	811292309	10.0%	4,076,068	13G/A	8/14/2026 Event 6/30/2026
Great Point Partners, LLC			10.0%	4,076,068
Dr. Jeffrey R. Jay, M.D.			10.0%	4,076,068
Ms. Lillian Nordahl			10.0%	4,076,068
Amanat Acquisition Corp 13G/A AMAN · G0375M101	AMAN	G0375M101	6.7%	500,000	13G/A	8/14/2026 Event 6/30/2026
Great Point Partners, LLC			6.7%	500,000
Dr. Jeffrey R. Jay, M.D.			6.7%	500,000
Ms. Lillian Nordahl			6.7%	500,000
Context Therapeutics Inc. 13G/A CNTX · 21077P108	CNTX	21077P108	2.4%	2,238,496	13G/A	5/15/2026 Event 3/31/2026
Great Point Partners, LLC			2.4%	2,238,496
Dr. Jeffrey R. Jay, M.D.			2.4%	2,238,496
Ms. Lillian Nordahl			2.4%	2,238,496
Zura Bio Limited 13G/A ZURA · G9TY5A101	ZURA	G9TY5A101	4.4%	4,215,930	13G/A	5/15/2026 Event 3/31/2026
Great Point Partners, LLC			4.4%	4,215,930
Dr. Jeffrey R. Jay, M.D.			4.4%	4,215,930
Ms. Lillian Nordahl			4.4%	4,215,930
SCYNEXIS, Inc. 13G SCYX · 811292200 Amended under CUSIP 811292309 on 8/14/2026	SCYX	811292200	10.0%	7,978,713	13G	4/7/2026 Event 3/31/2026
Great Point Partners, LLC			10.0%	7,978,713
Dr. Jeffrey R. Jay, M.D.			10.0%	7,978,713
Ms. Lillian Nordahl			10.0%	7,978,713
Sol-Gel Technologies Ltd. 13G SLGL · M8694L137	SLGL	M8694L137	8.5%	274,363	13G	3/31/2026 Event 3/24/2026
Great Point Partners, LLC			8.5%	274,363
Dr. Jeffrey R. Jay, M.D.			8.5%	274,363
Ms. Lillian Nordahl			8.5%	274,363
Inventiva S.A. 13G/A F5R343107		F5R343107	3.5%	6,783,269	13G/A	2/17/2026 Event 12/31/2025
Great Point Partners, LLC			3.5%	6,783,269
Dr. Jeffrey R. Jay, M.D.			3.5%	6,783,269
Ms. Lillian Nordahl			3.5%	6,783,269
Vistagen Therapeutics, Inc. 13G/A VTGN · 92840H400	VTGN	92840H400	4.95%	2,055,834	13G/A	2/17/2026 Event 12/31/2025
Great Point Partners, LLC			4.95%	2,055,834
Dr. Jeffrey R. Jay, M.D.			4.95%	2,055,834
Ms. Lillian Nordahl			4.95%	2,055,834
Vor Biopharma Inc. 13G/A VOR · 929033207	VOR	929033207	3.3%	1,370,107	13G/A	2/17/2026 Event 12/31/2025
Great Point Partners, LLC			3.3%	1,370,107
Dr. Jeffrey R. Jay, M.D.			3.3%	1,370,107
Ms. Lillian Nordahl			3.3%	1,370,107
Unicycive Therapeutics, Inc. 13G/A UNCY · 90466Y202	UNCY	90466Y202	4.5%	796,558	13G/A	11/14/2025 Event 9/30/2025
Great Point Partners, LLC			4.5%	796,558
Dr. Jeffrey R. Jay, M.D.			4.5%	796,558
Ms. Lillian Nordahl			4.5%	796,558
ProMIS Neurosciences Inc. 13G/A PMN · 74346M406 Amended under CUSIP 74346M505 on 2/17/2026	PMN	74346M406	10.0%	5,972,369	13G/A	11/14/2025 Event 9/30/2025
Great Point Partners, LLC			10.0%	5,972,369
Dr. Jeffrey R. Jay, M.D.			10.0%	5,972,369
Ms. Lillian Nordahl			10.0%	5,972,369
Outlook Therapeutics, Inc. 13G/A OTLK · 69012T305	OTLK	69012T305	4.99%	2,220,000	13G/A	8/14/2025 Event 6/30/2025
Great Point Partners, LLC			4.99%	2,220,000
Dr. Jeffrey R. Jay, M.D.			4.99%	2,220,000
Ms. Lillian Nordahl			4.99%	2,220,000
Optinose, Inc. 13G/A OPTN · 68404V209	OPTN	68404V209	4.9%	526,315	13G/A	5/15/2025 Event 3/31/2025
Great Point Partners, LLC			4.9%	526,315
Dr. Jeffrey R. Jay, M.D.			4.9%	526,315
Ms. Lillian Nordahl			4.9%	526,315
Unicycive Therapeutics, Inc. 13G/A UNCY · 90466Y103	UNCY	90466Y103	10.0%	11,473,166	13G/A	2/14/2025 Event 12/31/2024
Great Point Partners, LLC			10.0%	11,473,166
Dr. Jeffrey R. Jay, M.D.			10.0%	11,473,166
Ms. Lillian Nordahl			10.0%	11,473,166
Neurogene Inc. 13G/A NGNE · 64135M105	NGNE	64135M105	3.0%	442,761	13G/A	2/14/2025 Event 12/31/2024
Great Point Partners, LLC			3.0%	442,761
Dr. Jeffrey R. Jay, M.D.			3.0%	442,761
Ms. Lillian Nordahl			3.0%	442,761